» Authors » Jochen Maul

Jochen Maul

Explore the profile of Jochen Maul including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 905
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bluthner E, Dehe A, Buning C, Siegmund B, Prager M, Maul J, et al.
World J Gastroenterol . 2024 Aug; 30(29):3465-3478. PMID: 39156497
Background: Early diagnosis is key to prevent bowel damage in inflammatory bowel disease (IBD). Risk factor analyses linked with delayed diagnosis in European IBD patients are scarce and no data...
2.
Martini G, Tikhonova E, Rosati E, DeCelie M, Sievers L, Tran F, et al.
Nat Med . 2023 Sep; 29(10):2602-2614. PMID: 37749331
Aberrant CD4 T cell reactivity against intestinal microorganisms is considered to drive mucosal inflammation in inflammatory bowel diseases. The disease-relevant microbial species and the corresponding microorganism-specific, pathogenic T cell phenotypes...
3.
Ahlers J, Mantei A, Lozza L, Staber M, Heinrich F, Bacher P, et al.
Mucosal Immunol . 2022 Feb; 15(3):480-490. PMID: 35169232
Immunosuppressive Interleukin (IL)-10 production by pro-inflammatory CD4 T cells is a central self-regulatory function to limit aberrant inflammation. Still, the molecular mediators controlling IL-10 expression in human CD4 T cells...
4.
Schmidt C, Bachmann O, Baumgart D, Goetz M, Drvarov O, Kucharzik T, et al.
Z Gastroenterol . 2021 Jul; 59(10):1091-1109. PMID: 34284522
The complete and reliable documentation of endoscopic findings make up the crucial foundation for the treatment of patients with inflammatory bowel diseases such as Crohn´s disease and ulcerative colitis. These...
5.
Jessen B, Rodriguez-Sillke Y, Sonnenberg E, Schumann M, Kruglov A, Freise I, et al.
Clin Gastroenterol Hepatol . 2020 Apr; 19(4):721-731.e1. PMID: 32272247
Background & Aims: A substantial proportion patients with inflammatory bowel disease (IBD) have a primary non-response to infliximab; markers are needed to identify patients most likely to respond to treatment....
6.
Bacher P, Hohnstein T, Beerbaum E, Rocker M, Blango M, Kaufmann S, et al.
Cell . 2019 Feb; 176(6):1340-1355.e15. PMID: 30799037
Th17 cells provide protection at barrier tissues but may also contribute to immune pathology. The relevance and induction mechanisms of pathologic Th17 responses in humans are poorly understood. Here, we...
7.
Tangermann P, Branchi F, Itzlinger A, Aschenbeck J, Schubert S, Maul J, et al.
Clin Gastroenterol Hepatol . 2018 Sep; 17(9):1780-1787.e5. PMID: 30267867
Background & Aims: Point of care tests (POCTs) might be used to identify patients with undiagnosed celiac disease who require further evaluation. We performed a large multicenter study to determine...
8.
Bar F, Krause T, Stallmach A, Teich N, Maaser C, Maul J, et al.
Inflamm Intest Dis . 2018 Jul; 2(3):139-146. PMID: 30018965
Background And Aims: In Crohn's disease (CD) patients still remain refractory to current regimens, including biologicals. Previous data from small single-center studies indicated cyclophosphamide pulse therapy (CPT) to be effective...
9.
Giesecke C, Meyer T, Durek P, Maul J, Preiss J, Jacobs J, et al.
J Immunol . 2018 May; 200(12):3981-3992. PMID: 29735481
There are currently limited insights into the progression of human primary humoral immunity despite numerous studies in experimental models. In this study, we analyzed a primary and related secondary parenteral...
10.
Becker J, Berger F, Schindlbeck K, Poddubnyy D, Koch P, Preiss J, et al.
Int J Colorectal Dis . 2018 Apr; 33(7):955-962. PMID: 29610943
Background And Aims: In patients with inflammatory bowel disease (IBD), restless legs syndrome (RLS) may occur as an extraintestinal disease manifestation. Iron deficiency (ID) or folate deficiency/vitamin B deficiency (FD/VBD)...